Dr. Lowe is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
601 Childrens Ln
Norfolk, VA 23507Phone+1 757-668-7243Fax+1 757-668-7811- Is this information wrong?
Education & Training
- University of TennesseeFellowship, Pediatric Hematology/Oncology, 2001 - 2004
- University of Texas Southwestern Medical CenterResidency, Pediatrics, 1998 - 2001
- Emory University School of MedicineClass of 1998
Certifications & Licensure
- VA State Medical License 2004 - 2026
- NC State Medical License 2020 - 2022
- TN State Medical License 2001 - 2006
- TX State Medical License 1999 - 2002
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
- Fellow (FAAP) American Academy of Pediatrics
Clinical Trials
- Combination Chemotherapy With or Without Peripheral Stem Cell Transplantation, Radiation Therapy, and/or Surgery in Treating Patients With Ewing's Sarcoma Start of enrollment: 2001 Feb 01
- Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma Start of enrollment: 2001 Oct 18
- Vincristine, Dactinomycin, and Cyclophosphamide With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Low-Risk Rhabdomyosarcoma Start of enrollment: 2004 Sep 04
- Join now to see all
Publications & Presentations
PubMed
- 2 citationsChildren's Oncology Group's 2023 blueprint for research: Non-Hodgkin lymphoma.Nader Kim El-Mallawany, Sarah Alexander, Mark Fluchel, Robert J Hayashi, Eric J Lowe, Lisa Giulino-Roth, Birte Wistinghausen, Michelle Hermiston, Carl E Allen> ;Pediatric Blood & Cancer. 2023 Sep 1
- 2 citationsCellular and humoral immunotherapy in children, adolescents and young adults with non-Hodgkin lymphoma.Yaya Chu, Aliza Gardenswartz, Caroline Diorio, Lianna J Marks, Eric Lowe, David T Teachey, Mitchell S Cairo> ;Best Practice & Research. Clinical Haematology. 2023 Mar 1
- 12 citationsCrizotinib in Combination With Chemotherapy for Pediatric Patients With ALK+ Anaplastic Large-Cell Lymphoma: The Results of Children's Oncology Group Trial ANHL12P1.Eric J Lowe, Anne F Reilly, Megan S Lim, Thomas G Gross, Lauren Saguilig, Donald A Barkauskas, Rui Wu, Sarah Alexander, Catherine M Bollard> ;Journal of Clinical Oncology. 2023 Apr 10
- Join now to see all
Press Mentions
- Crizotinib Combined with Chemotherapy in Pediatric ALK-Positive Anaplastic Large Cell LymphomaJanuary 5th, 2023
- Adding Brentuximab Vedotin to Chemotherapy Improves Outcomes in Pediatric ALK-Positive ALCLMay 1st, 2021
Professional Memberships
- Member
- Fellow
Hospital Affiliations
- Children's Hospital of The King's DaughtersNorfolk, Virginia
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: